Zimmer Biomet Holdings Statistics
Total Valuation
ZBH has a market cap or net worth of $19.24 billion. The enterprise value is $26.17 billion.
| Market Cap | 19.24B |
| Enterprise Value | 26.17B |
Important Dates
The last earnings date was Wednesday, November 5, 2025, before market open.
| Earnings Date | Nov 5, 2025 |
| Ex-Dividend Date | Sep 30, 2025 |
Share Statistics
ZBH has 198.21 million shares outstanding. The number of shares has decreased by -3.29% in one year.
| Current Share Class | 198.21M |
| Shares Outstanding | 198.21M |
| Shares Change (YoY) | -3.29% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 0.13% |
| Owned by Institutions (%) | 99.72% |
| Float | 197.74M |
Valuation Ratios
The trailing PE ratio is 24.07 and the forward PE ratio is 11.55. ZBH's PEG ratio is 1.77.
| PE Ratio | 24.07 |
| Forward PE | 11.55 |
| PS Ratio | 2.41 |
| Forward PS | 2.23 |
| PB Ratio | 1.51 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.94 |
| P/OCF Ratio | 11.41 |
| PEG Ratio | 1.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.91, with an EV/FCF ratio of 21.69.
| EV / Earnings | 32.50 |
| EV / Sales | 3.27 |
| EV / EBITDA | 9.91 |
| EV / EBIT | 16.70 |
| EV / FCF | 21.69 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.65.
| Current Ratio | 2.43 |
| Quick Ratio | 1.21 |
| Debt / Equity | 0.65 |
| Debt / EBITDA | 3.04 |
| Debt / FCF | 6.83 |
| Interest Coverage | 5.54 |
Financial Efficiency
Return on equity (ROE) is 6.42% and return on invested capital (ROIC) is 4.89%.
| Return on Equity (ROE) | 6.42% |
| Return on Assets (ROA) | 4.33% |
| Return on Invested Capital (ROIC) | 4.89% |
| Return on Capital Employed (ROCE) | 7.43% |
| Revenue Per Employee | $471,229 |
| Profits Per Employee | $47,371 |
| Employee Count | 17,000 |
| Asset Turnover | 0.35 |
| Inventory Turnover | 0.94 |
Taxes
In the past 12 months, ZBH has paid $214.50 million in taxes.
| Income Tax | 214.50M |
| Effective Tax Rate | 20.99% |
Stock Price Statistics
The stock price has decreased by -11.93% in the last 52 weeks. The beta is 0.61, so ZBH's price volatility has been lower than the market average.
| Beta (5Y) | 0.61 |
| 52-Week Price Change | -11.93% |
| 50-Day Moving Average | 96.98 |
| 200-Day Moving Average | 99.14 |
| Relative Strength Index (RSI) | 57.49 |
| Average Volume (20 Days) | 2,621,884 |
Short Selling Information
The latest short interest is 7.27 million, so 3.67% of the outstanding shares have been sold short.
| Short Interest | 7.27M |
| Short Previous Month | 6.80M |
| Short % of Shares Out | 3.67% |
| Short % of Float | 3.68% |
| Short Ratio (days to cover) | 5.84 |
Income Statement
In the last 12 months, ZBH had revenue of $8.01 billion and earned $805.30 million in profits. Earnings per share was $4.03.
| Revenue | 8.01B |
| Gross Profit | 5.74B |
| Operating Income | 1.57B |
| Pretax Income | 1.02B |
| Net Income | 805.30M |
| EBITDA | 2.64B |
| EBIT | 1.57B |
| Earnings Per Share (EPS) | $4.03 |
Balance Sheet
The company has $1.31 billion in cash and $8.24 billion in debt, giving a net cash position of -$6.93 billion or -$34.97 per share.
| Cash & Cash Equivalents | 1.31B |
| Total Debt | 8.24B |
| Net Cash | -6.93B |
| Net Cash Per Share | -$34.97 |
| Equity (Book Value) | 12.77B |
| Book Value Per Share | 64.36 |
| Working Capital | 3.43B |
Cash Flow
In the last 12 months, operating cash flow was $1.69 billion and capital expenditures -$479.30 million, giving a free cash flow of $1.21 billion.
| Operating Cash Flow | 1.69B |
| Capital Expenditures | -479.30M |
| Free Cash Flow | 1.21B |
| FCF Per Share | $6.09 |
Margins
Gross margin is 71.62%, with operating and profit margins of 19.56% and 10.05%.
| Gross Margin | 71.62% |
| Operating Margin | 19.56% |
| Pretax Margin | 12.76% |
| Profit Margin | 10.05% |
| EBITDA Margin | 32.96% |
| EBIT Margin | 19.56% |
| FCF Margin | 15.06% |
Dividends & Yields
This stock pays an annual dividend of $0.96, which amounts to a dividend yield of 0.99%.
| Dividend Per Share | $0.96 |
| Dividend Yield | 0.99% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 23.80% |
| Buyback Yield | 3.29% |
| Shareholder Yield | 4.28% |
| Earnings Yield | 4.19% |
| FCF Yield | 6.27% |
Analyst Forecast
The average price target for ZBH is $108.56, which is 11.84% higher than the current price. The consensus rating is "Buy".
| Price Target | $108.56 |
| Price Target Difference | 11.84% |
| Analyst Consensus | Buy |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 4.88% |
| EPS Growth Forecast (5Y) | 18.75% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ZBH has an Altman Z-Score of 2.56 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.56 |
| Piotroski F-Score | 6 |